MarketsandMarkets: Brazil Biomaterials Market Worth US$1.7 Billion by 2015By Markets And Markets, PRNE
Tuesday, May 3, 2011
DALLAS, May 4, 2011 - According to a new market research report, 'Brazil Biomaterials Market
(2010-2015)', published by MarketsandMarkets (
www.marketsandmarkets.com), the biomaterials market in Brazil is
expected to be worth US$1.7 billion by 2015, and is expected to grow at a
CAGR of 19.5% from 2010 to 2015.
Browse 48 market data tables and in-depth TOC on Brazil Biomaterials
Early buyers will receive 10% customization on reports
Brazil, off late, has emerged as an attractive destination for medical
tourism because of its quality services, excellent medical facilities, and
treatment at affordable prices (about 50% less than that of U.S.).
The private healthcare delivery market in Brazil will see new entrants
and some consolidation. This is likely to increase the number of hospitals
and the care units. For example, the International Financial Corporation
(IFC) has partially financed the private hospital chain 'Hospital e
Maternidade Analia Franco' of the Sao Luiz Group. The IFC extended a loan of
$17 million with a 13-year final maturity and additional long-term fund of
the same amount to furnish and equip the hospital. Such developments are
likely to increase the number of hospitals or care units in the country.
In the biomaterials market, materials such as metals, ceramics, and
polymers are used in various products such as artificial knee, cardiac
stents, thrombin-based hemostats, catheter, and others. Metals account for
the largest share; i.e. 36% of the total biomaterials market in 2010. Metals
have a natural property of biocompatibility which is important for various
treatments and have less wear and tear rate; this increases the demand for
metals in biomaterials. Metals are further classified into pure form metals
and alloys. Ceramics and polymers account for 25% and 24% respectively of the
The National Health Surveillance Agency (Agencia Nacional de Vigilancia
Sanitaria or ANVISA), established in January 1999, is an autonomous agency in
Brazil, which works with the Ministry of Health under a management contract.
ANVISA is responsible for regulating medical equipment and pharmaceuticals
and is equivalent to the U.S. Food & Drug Administration (FDA). It is
mandatory to have all devices registered with ANVISA before they are launched
in the market.
Aging population (population above 60 years is expected to reach 24
million by 2012), higher life expectancy, and increase in the incidences of
'lifestyle and chronic diseases' such as cardiovascular diseases have
influenced the growth of biomaterial products. According to the World Health
Organization, 32% of the total mortality in Brazil is due to cardiovascular
diseases. Such a high incidence of diseases will increase the demand for
cardiovascular biomaterial products such as cardiac stents.
The increasing number of application areas that allow suppliers a larger
bandwidth for their material development mainly drives the supply side of the
market. The increasing application areas for biomaterial products are
attracting more companies to invest in research and development of newer
materials and improve the performance of the existing products; leading to an
increase in demand and boost the market size. Biomaterials are used in a
variety of applications ranging from tissue replacements and surface coating
to medical devices. They are also widely used in drug delivery, gene
transfer, and tissue engineering applications.
Scope of the report
This report analyzes the Brazil biomaterials markets based on:
- Biomaterial market, by products: - Orthopedic - Cardiovascular - Wound care - Gastrointestinal - Urological - Plastic surgery - Others - Biomaterial market, by materials: - Metals - Polymers - Ceramics - Composites - Biomaterial market, by applications: - General surgery - Surgical appliances and supplies - Surgical and medical instruments - dental products - Electro medical equipment - Other applications
In addition to market sizes and forecasts, the report also provides a
detailed analysis of the market trends and factors influencing market growth,
offering in-depth geographic analyses of the biomaterial market in Brazil.
The report draws the competitive landscape of the Brazil biomaterial market,
providing an in-depth comparative analysis of the technological and marketing
strategies adopted by the key players in order to gain an edge over the their
Contact our representative to sponsor this report.
MarketsandMarkets (M&M) is a global market research and consulting
company based in the U.S. We publish strategically analyzed market research
reports and serve as a business intelligence partner to Fortune 500 companies
across the world. MarketsandMarkets also provides multi-client reports,
company profiles, databases, and custom research services.
M&M covers thirteen industry verticals; including advanced materials,
automotives and transportation, banking and financial services,
biotechnology, chemicals, consumer goods, energy and power, food and
beverages, industrial automation, medical devices, pharmaceuticals,
semiconductor and electronics, and telecommunications and IT.
We at MarketsandMarkets are inspired to help our clients grow by
providing apt business insight with our huge market intelligence repository.
To know more about us and our reports, please visit our website
Contact: Mr. Rohan 7557 Rambler Road, Suite 727, Dallas, TX 75231 Tel: +1-888-6006-441 Email: firstname.lastname@example.org www.marketsandmarkets.com marketsandmarkets.blogspot.com twitter.com/marketsmarkets
Tags: Brazil, Dallas, Markets and Markets, May 4, texas